Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics.
Vesalius Therapeutics is focused on redefining the understanding and treatment of the diseases that drive ninety percent of human illness.
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Denali Therapeutics is dedicated to defeating neurodegenerative diseases to deliver safe and effective medicines to patients and families.
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Expedition Medicines is developing AI to stretch the bounds of medicine.
Extuitive is an AI-first business that aims to revolutionize the conception and validation of new consumer goods and creatives.
Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.
Etiome, a company redefining how we detect and preempt disease progression.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Apriori Bio offers a platform for creating variant-resilient vaccines and provides real-time insights to prepare for future outbreaks.
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.
Flagship Pioneering has invested in 70 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Flagship Pioneering's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 23 different industry categories.
Among tracked funding rounds, Laronde received $440.0M in a Series B round. Flagship Pioneering's total known invested capital is $4.6B.
Flagship Pioneering's average investment size is $65.8M across its portfolio of 70 companies.
Recent Flagship Pioneering portfolio additions include Axcella, Cellarity, Codiak Biosciences, Senda Biosciences, ProFound Therapeutics. These companies were founded in 2020 or later.